Organon & Co 已达成并完成一项授权协议,获得 Sebela Pharmaceuticals 旗下无激素宫内节育器 Miudella® 的相关权益。此举旨在拓展 Organon 在女性健康领域的创新产品组合。
Organon & Co 已达成并完成一项授权协议,获得 Sebela Pharmaceuticals 旗下无激素宫内节育器 Miudella® 的相关权益。此举旨在拓展 Organon 在女性健康领域的创新产品组合。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.